Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03954080 · ClinicalTrials.gov registry record · NA

Trialing of ISS in Patients With CRPS

A NA study of Crps I and Causalgia, sponsored by Millennium Pain Center.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT03954080 is a NA study of Crps I and Causalgia that has completed, run by Millennium Pain Center. The registered enrollment target is 16 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03954080, a NA study of Crps I and Causalgia, has completed, sponsored by Millennium Pain Center.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

This is a multi-center, prospective, open-label, single-arm, observational, feasibility study. The goal of this study is to determine the feasibility of intra-spinal stimulation with optimal paresthesia coverage therapy for chronic pain relief in patients with complex regional pain syndrome type I or causalgia. Up to 20 patients with intractable chronic severe limb pain associated with complex regional pain syndrome (CRPS) will be included in the study. A standard of care trial phase to test a subjects' response to Intraspinal-Optimal Stim therapy will be conducted during a 3 to 10-day period. Patients that obtain 50% or greater pain relief during the trial period will undergo permanent implantation of the device. Primary outcome will evaluate pain response at 3 months of therapy, based on NPRS pain score relative to baseline. Patients will be followed up for 6 months after the start of therapy.

Conditions Studied

Interventions

  • DEVICE Intraspinal-optimal stim therapy

Study Locations (1)

Illinois

  • Millennium Pain Center - Bloomington

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2019-06-13
Est. Completion 2022-03-31
Phase NA

Sponsor

Millennium Pain Center

2 total trials

What the Registry Record Tells You About NCT03954080

The ClinicalTrials.gov registry entry for NCT03954080 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Millennium Pain Center, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Crps I appearing as the primary indexed condition, and to 1 intervention - of which Intraspinal-optimal stim therapy is the first listed.

NCT03954080 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT03954080 about?

NCT03954080 is a clinical study titled "Trialing of ISS in Patients With CRPS". This is a multi-center, prospective, open-label, single-arm, observational, feasibility study. The goal of this study is to determine the feasibility of intra-spinal stimulation with optimal paresthesia coverage therapy for chronic pain relief in patients with complex regional pain syndrome type I o...

What is the current status of trial NCT03954080?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2019-06-13. Estimated completion is 2022-03-31.

What conditions does trial NCT03954080 study?

This clinical trial studies the following conditions: Crps I, Causalgia.

What interventions are being tested in trial NCT03954080?

The interventions under investigation include: Intraspinal-optimal stim therapy (DEVICE).

Who is sponsoring clinical trial NCT03954080?

This trial is sponsored by Millennium Pain Center, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03954080 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.